Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Recalling firm

Sun Pharmaceutical Industries INC

NDC code

62756-590-88

Origin

NJ, United States

Initiated by

Voluntary: Firm initiated

FDA recall number

D-0084-2024

Other Liothyronine recalls

See all

Class II · Moderate risk Terminated Dec 4, 2023

Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury…

Reason Failed Impurities/Degradation Specifications

Sun Pharmaceutical Industries INC NDC 62756-589-88 D-0150-2024

Class II · Moderate risk Terminated Oct 20, 2023

Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury…

Reason Failed Impurities/Degradation Specifications.

Sun Pharmaceutical Industries INC NDC 62756-589-88 D-0083-2024

Class II · Moderate risk Terminated Sep 17, 2020

Nature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg, Levothyroxine (T4) 38 mcg…

Reason CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be…

PD-Rx Pharmaceuticals, Inc. NDC 43063-819-01 D-0005-2021

Class II · Moderate risk Terminated Sep 2, 2020

Nature-Throid, 1.5 Grain, (97.5 mg), (Thyroid U.S.P. 1.5 gr. (97.5mg)/Liothyronine (T3) 13.5mcg/Levothyroxine (T4) 57mcg…

Reason CGMP Deviations

Preferred Pharmaceuticals, Inc. NDC 68788-7605-09 D-1624-2020

Class II · Moderate risk Terminated Sep 2, 2020

Nature-Throid, 1 Grain, 65 mg (Thyroid U.S.P. 1 gr. (65mg)/Liothyronine (T3) 9mcg/Levothyroxine (T4) 38mcg, packaged in a)…

Reason CGMP Deviations

Preferred Pharmaceuticals, Inc. NDC 68788-7604-09 D-1623-2020